A systematic review of management of neuroendocrine tumors: An experience from a tertiary care centre from India
- 1 January 2014
- journal article
- review article
- Published by Polaris in Clinical Cancer Investigation Journal
- Vol. 3 (5), 363
- https://doi.org/10.4103/2278-0513.138052
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Neuroendocrine TumorsPublished by Springer Science and Business Media LLC ,2011
- A phase II study of capecitabine, oxaliplatin, and bevacizumab for metastatic or unresectable neuroendocrine tumors.Journal of Clinical Oncology, 2010
- A prospective, multi-institutional phase II study of GW786034 (pazopanib) and depot octreotide (sandostatin LAR) in advanced low-grade neuroendocrine carcinoma (LGNEC).Journal of Clinical Oncology, 2010